Vocational education company Adtalem Global Education (NYSE:ATGE) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.9% year on year to $466.1 million. The company’s full-year revenue guidance of $1.77 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $1.92 per share was 16.2% above analysts’ consensus estimates.
Is now the time to buy ATGE? Find out in our full research report (it’s free).
Adtalem (ATGE) Q1 CY2025 Highlights:
- Revenue: $466.1 million vs analyst estimates of $446.4 million (12.9% year-on-year growth, 4.4% beat)
- Adjusted EPS: $1.92 vs analyst estimates of $1.65 (16.2% beat)
- Adjusted EBITDA: $127.8 million vs analyst estimates of $111.2 million (27.4% margin, 14.9% beat)
- The company lifted its revenue guidance for the full year to $1.77 billion at the midpoint from $1.75 billion, a 1.3% increase
- Management raised its full-year Adjusted EPS guidance to $6.50 at the midpoint, a 4.8% increase
- Operating Margin: 20.9%, up from 19.5% in the same quarter last year
- Market Capitalization: $4.36 billion
StockStory’s Take
Adtalem’s first-quarter results were shaped by significant enrollment growth across its core institutions and continued investment in digital learning tools. CEO Steve Beard highlighted Chamberlain University’s expansion of its BSN Online program and Walden University’s strong student persistence, both contributing to the company’s momentum. Beard pointed to Walden’s use of predictive analytics to improve student retention, stating, “We’ve increased and enhanced our ability to intervene in the student journey in ways that keep our students pacing through materials in ways that ensure they’re successful.” Growth in the Medical and Veterinary segment, though modest, was also noted, with Beard referencing increased inquiry-to-enrollment conversion. Segment performance benefited from strategic initiatives aimed at expanding access and improving academic outcomes.
Looking ahead, management’s updated guidance reflects expectations for continued enrollment gains and margin expansion, underpinned by ongoing investments in digital platforms, program capacity, and geographic reach. CFO Bob Phelan explained that the company plans to increase growth investments in the coming quarter to “set us up well heading into next year,” suggesting a focus on both operational leverage and long-term scalability. Beard indicated that Adtalem is exploring new program launches and potential geographic expansion, stating, “There are new programs we’d like to bring online... and the vehicles we would use to accomplish bringing on that new capacity are everything from investments in existing programs to acquiring new programs, to standing up new de novo programs.”
Key Insights from Management’s Remarks
Management attributed the quarter’s outperformance to broad-based enrollment gains, investments in student-facing digital tools, and ongoing partnerships with healthcare providers.
- Enrollment-driven revenue growth: Significant student enrollment increases at Chamberlain University and Walden University were primary drivers, supported by expanded online offerings and high persistence rates.
- Digital innovation impact: Walden University’s implementation of predictive analytics and digital engagement tools improved student retention and academic outcomes, with Beard noting near-record persistence across large programs.
- Healthcare partnerships and specialty focus: Chamberlain’s Practice Ready Specialty Focused program, developed with healthcare partners, gave students hands-on exposure to high-demand specialties, which management believes improves job placement and employer satisfaction.
- Medical and Veterinary segment stabilization: While enrollment returned to growth in this segment, margins declined due to timing of investments and structural costs; management views this as positioning for future expansion.
- Share repurchase and capital allocation: Completion of a $300 million share repurchase and authorization of an additional $150 million program were highlighted, reflecting a focus on returning capital while funding innovation and operational growth.
Drivers of Future Performance
Adtalem expects that sustained enrollment momentum, enhanced digital tools, and expanded program capacity will drive continued revenue and margin growth in the coming quarters.
- Capacity and program expansion: Management plans to invest in expanding existing program capacity and launching new offerings, including geographic expansion and additions in high-demand healthcare fields, to capture unmet market demand.
- Innovation in student engagement: Continued deployment of predictive analytics and digital interventions is expected to further improve student retention and success, which management sees as key to profitability and long-term growth.
- Regulatory and funding environment: While management does not anticipate near-term funding pressure or regulatory headwinds, ongoing monitoring of legislative and Department of Education developments remains a priority given the sector’s sensitivity to policy changes.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will monitor (1) the pace and effectiveness of Adtalem’s investments in new program capacity and geographic reach, (2) improvements in student retention and academic outcomes driven by digital engagement tools, and (3) stability and recovery of margins in the Medical and Veterinary segment as operational investments mature. Developments in federal education policy or funding will also be important to watch.
Adtalem currently trades at a forward P/E ratio of 17.5×. In the wake of earnings, is it a buy or sell? The answer lies in our full research report (it’s free).
Stocks That Trumped Tariffs
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.